-
Mashup Score: 0american stroke conference 2023 - Google Search - 1 year(s) ago
6 days ago — ISC 2023 is a three-day conference held in February, delivering the latest stroke and brain health science from around the world to an …Pre-Cons and Stroke Nursing Symposia: February 7, 2023. ISC Sessions: February 8–10, 2023. Kay Bailey Hutchison Convention Center | Dallas, Texas + Virtual.The International Stroke Conference 2023 will be a hybrid event held Feb. 8-10, 2023 in…
Source: www.google.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 6
Background: Aneurysmal subarachnoid hemorrhage (aSAH) is associated with high mortality and morbidity. We aimed to determine the relative benefits of pharmacological prophylactic treatments in patien
Source: StrokeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#STROKE #Meta-Analysis reports #nimodipine and #cilostazol improved disability, whereas #clazosentan, #nicardipine, #fasudil and #magnesium reduced delayed cerebral ischemia in aneurysmal #SAH https://t.co/wmypF6Apoe https://t.co/oth3jHvgbM
-
-
Mashup Score: 1Cilostazol Versus Aspirin on White Matter Changes in Cerebral Small Vessel Disease: A Randomized Controlled Trial - 2 year(s) ago
Background and Purpose: Cerebral small vessel disease is characterized by progressive cerebral white matter changes (WMCs). This study aimed to compare the effects of cilostazol and aspirin on change
Source: StrokeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
An RCT in Korea showed #Cilostazol was not associated with decreased #WhiteMatterDisease progression when compared to #aspirin in patients with #SVD; secondary analysis showed lower risk of stroke in the #Cilostazol group #ClinicalTrials #STROKE https://t.co/Dpn0mfNtLM https://t.co/lo7KolxE1l
-
-
Mashup Score: 1Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke - 2 year(s) ago
Background and Objectives Long-term treatment with the combination of cilostazol with aspirin or clopidogrel showed a lower risk of stroke recurrence compared to aspirin or clopidogrel alone after high-risk noncardioembolic ischemic stroke in a randomized trial. We aimed to determine whether the effect of the dual medication compared to monotherapy on risk of recurrent ischemic stroke differs…
Source: NeurologyCategories: Latest Headlines, NeurologyTweet-
This study provides Class II evidence that for patients with acute noncardioembolic #stroke taking either aspirin or clopidogrel, the addition of #cilostazol 15–180 days after stroke onset decreases the risk of recurrent ischemic stroke. https://t.co/VrZviuOCP7 #NeuroTwitter https://t.co/kg9VWzswo5
-
-
Mashup Score: 2Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke: A CSPS.com Trial Post Hoc Analysis - 2 year(s) ago
Background and Objectives: Long-term medication with the combination of cilostazol with aspirin or clopidogrel showed a lower risk of stroke recurrence compared to aspirin or clopidogrel alone, after onset of high-risk non-cardioembolic ischemic stroke in a randomized trial. We aimed to determine whether the effect of the dual medication compared to monotherapy on risk of recurrent ischemic…
Source: NeurologyCategories: Latest Headlines, NeurologyTweet-
This study provides Class II evidence that for patients with acute non-cardioembolic #stroke, taking either aspirin or clopidogrel, the addition of #cilostazol 15 to 180 days after stroke onset decreases the risk of recurrent ischemic stroke. https://t.co/2fXZ0hcOik https://t.co/83Mozx6Jrm
-
-
Mashup Score: 7Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Latest Headlines, NeurologyTweet-
Study via @GreenJournal finds DAPT plus #cilostazol is most effective 15 days or later after #stroke onset. An editorial from @AANMember Drs. @tmadsenem and de Havenon said the study adds clarity to the optimal timing of the treatment. https://t.co/Uh2VGkqgto #NeuroTwitter https://t.co/6DOQBQECOm
-
-
Mashup Score: 1Cilostazol for peripheral arterial disease - 3 year(s) ago
Background Blockages in the arteries to the legs – peripheral arterial disease – affect 20% of people aged over 70 years and 4% to 12% of people aged 55 to 70 years. Approximately 40% of those with peripheral arterial disease complain of pain in the legs or buttocks that occurs with exercise and subsides with rest. This is known as intermittent claudication and these symptoms are an…
Source: www.cochrane.orgCategories: General Medicine News, Latest HeadlinesTweet-
RT @CochraneVasc: #CochraneEvidence updated #PAD #IC #cilostazol #legsmatter https://t.co/cOdNkDsfAd @CochraneLibrary @VSGBI @VascularSVS @…
-
-
Mashup Score: 0
Purpose: The aim of this study is to examine the potential effect of cilostazol and inflammation on cognitive impairment after stroke in an Asian population. Me…
Source: SAGE JournalsCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
The aim of this study is to examine the potential effect of #cilostazol and inflammation on cognitive impairment after #stroke in an Asian population. https://t.co/gqwzQMV9Zz
-
-
Mashup Score: 3
Background and Purpose: Cilostazol, a phosphodiesterase 3’ inhibitor, is used in Asia-Pacific countries for stroke prevention, but rarely used elsewhere. In addition to weak antiplatelet effects, i…
Source: StrokeCategories: Latest Headlines, NeurologyTweet-
Systematic Review and Meta-Analysis on #Cilostazol for Secondary Stroke Prevention and Cognitive Decline #STROKE Open Access https://t.co/R1Y9jg7ZVb https://t.co/hoWr7dUiTA
-
@DAICeditor @American_Stroke A preliminary #study of #cilostazol and #isosorbide_mononitrate suggests these two medications were safe and well-tolerated by adults who have experienced small vessel #stroke, when taken alone or together: https://t.co/hrFybNOFWB #ISC23 #ISC2023